Prospective Multicentric Study Comparing the Acute Hemodynamic Effect of Three Modes of Stimulation in Cardiac Resynchronization Therapy Recipients (3 STIM)
Primary Purpose
Heart Failure, Cardiac Resynchronization Therapy
Status
Terminated
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Device programming of ABBOTT CRT pacemaker or defibrillator
Sponsored by
About this trial
This is an interventional treatment trial for Heart Failure focused on measuring Cardiac Resynchronization Therapy, Atrioventricular delay optimization, Multipoint pacing, Negative atrioventricular hysteresis, Non invasive hemodynamic optimization, Heart Failure
Eligibility Criteria
Inclusion Criteria:
- Patient older than 18
- Implantation of a CRT (CRT-P or CRT-D) less than 3 months before inclusion
- MPP and SyncAV-enabled ABBOTT Quadripolar CRT pacing system
- Patient who had signed an informed consent and is willing to comply with study requirements
- De novo implantation
- Patient covered by national healthcare insurance
Exclusion Criteria:
- Permanent/persistant atrial fibrillation/ supra-ventricular tachycardia
- Pacing indication for 2nd or 3rd degree AV block
- Upgrading from non-CRT system
- Pregnant or breastfeeding women
- Adult under legal protection
Sites / Locations
- Gehm Site D'Eaubonne
- Cmc Ambroise Pare
- CHU Poitiers
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
CRT device
Arm Description
Patients implanted with a CRT device who will undergo a non-invasive hemodynamic evaluation of different pacing modes
Outcomes
Primary Outcome Measures
Hemodynamic response
Highest Systolic Blood Pressure (SBP) obtained by optimization of the mode of stimulation
Secondary Outcome Measures
Other hemodynamical response
Cardiac output
Other hemodynamical response
Systolic ejection volume
Other hemodynamical response
dP/dT
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT03779802
Brief Title
Prospective Multicentric Study Comparing the Acute Hemodynamic Effect of Three Modes of Stimulation in Cardiac Resynchronization Therapy Recipients
Acronym
3 STIM
Official Title
Comparison of the Acute Hemodynamic Effect of Three Modes of Stimulation in Cardiac Resynchronization.
Study Type
Interventional
2. Study Status
Record Verification Date
April 2020
Overall Recruitment Status
Terminated
Why Stopped
With the current health situation, we do not anticipate a significant resumption of recruitment for several months.
Study Start Date
April 23, 2019 (Actual)
Primary Completion Date
April 18, 2020 (Actual)
Study Completion Date
April 18, 2020 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
CMC Ambroise Paré
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Cardiac Resynchronization Therapy (CRT) is an established treatment for patients with systolic heart failure and bundle branch block, improving functional capacity, quality of life and reducing morbi-mortality.
Adjusting atrio-ventricular (AV) delay, vector optimization and choice of different modes of stimulation can influence the acute hemodynamical consequences of CRT but also its medium-term and long-term clinical and echocardiographic effects.
The aim of the present prospective study is to investigate whether the different stimulation modes lead to different acute hemodynamic response, by evaluating the highest systolic pressure using the Finapress ® method.
Detailed Description
This study is a non-randomized, prospective, interventional, multicentric study.
Patients implanted with an Abbott ® CRT pacemaker or defibrillator since less than 3 months are eligible for the study.
Recruited patients will be submitted to a non-invasive evaluation of different pacing modes. This will be performed using the Finapress NOVA device, which records blood pressure with a digital cuff. The peak of blood pressure will correspond to the optimal device settings
Three modes of stimulation of ABBOTT CRT devices will be compared:
Classical bi-ventricular pacing mode at nominal value and with AV delay optimization
SyncAV mode at nominal value or with left ventricular preexcitation optimization
Multipoint Pacing (MPP) mode, alone or in combination with SyncAV mode This is an acute evaluation study without scheduled follow-up.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Failure, Cardiac Resynchronization Therapy
Keywords
Cardiac Resynchronization Therapy, Atrioventricular delay optimization, Multipoint pacing, Negative atrioventricular hysteresis, Non invasive hemodynamic optimization, Heart Failure
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
CRT device
Arm Type
Experimental
Arm Description
Patients implanted with a CRT device who will undergo a non-invasive hemodynamic evaluation of different pacing modes
Intervention Type
Other
Intervention Name(s)
Device programming of ABBOTT CRT pacemaker or defibrillator
Intervention Description
Comparison of the acute hemodynamic effect of three modes of stimulation in ABBOTT CRT devices (Biventricular, SyncAV and MPP modes) by using the Finapress® NOVA method to assess the highest systolic blood pressure (SBP) during the programming session Comparison of the acute hemodynamic effect of three modes of stimulation in ABBOTT CRT devices (Biventricular, SyncAV and MPP modes) by using the Finapress® NOVA method to assess the highest systolic blood pressure (SBP) during the programming session.
Primary Outcome Measure Information:
Title
Hemodynamic response
Description
Highest Systolic Blood Pressure (SBP) obtained by optimization of the mode of stimulation
Time Frame
day 0
Secondary Outcome Measure Information:
Title
Other hemodynamical response
Description
Cardiac output
Time Frame
day 0
Title
Other hemodynamical response
Description
Systolic ejection volume
Time Frame
day 0
Title
Other hemodynamical response
Description
dP/dT
Time Frame
day 0
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patient older than 18
Implantation of a CRT (CRT-P or CRT-D) less than 3 months before inclusion
MPP and SyncAV-enabled ABBOTT Quadripolar CRT pacing system
Patient who had signed an informed consent and is willing to comply with study requirements
De novo implantation
Patient covered by national healthcare insurance
Exclusion Criteria:
Permanent/persistant atrial fibrillation/ supra-ventricular tachycardia
Pacing indication for 2nd or 3rd degree AV block
Upgrading from non-CRT system
Pregnant or breastfeeding women
Adult under legal protection
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ghassan MD MOUBARAK
Organizational Affiliation
CMC Ambroise Paré
Official's Role
Principal Investigator
Facility Information:
Facility Name
Gehm Site D'Eaubonne
City
Eaubonne
State/Province
Val-d'Oise
ZIP/Postal Code
95600
Country
France
Facility Name
Cmc Ambroise Pare
City
Neuilly sur seine
ZIP/Postal Code
92200
Country
France
Facility Name
CHU Poitiers
City
Poitiers
Country
France
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
33128179
Citation
Ferchaud V, Garcia R, Bidegain N, Degand B, Milliez P, Pezel T, Moubarak G. Non-invasive hemodynamic determination of patient-specific optimal pacing mode in cardiac resynchronization therapy. J Interv Card Electrophysiol. 2021 Nov;62(2):347-356. doi: 10.1007/s10840-020-00908-6. Epub 2020 Oct 30.
Results Reference
derived
Learn more about this trial
Prospective Multicentric Study Comparing the Acute Hemodynamic Effect of Three Modes of Stimulation in Cardiac Resynchronization Therapy Recipients
We'll reach out to this number within 24 hrs